Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

CMMB Chemomab Therapeutics

2.490
+0.080+3.32%
Close 09/30 16:00 ET
2.380
-0.110-4.42%
Post Mkt Price 09/30 16:30 ET
High
2.590
Open
2.560
Turnover
19.79K
Low
2.400
Pre Close
2.410
Volume
7.92K
Market Cap
28.46M
P/E(TTM)
Loss
52wk High
13.190
Shares
11.43M
P/E(Static)
Loss
52wk Low
2.250
Float Cap
12.75M
Bid/Ask %
0.00%
Historical High
184.000
Shs Float
5.12M
Volume Ratio
0.38
Historical Low
2.250
Dividend TTM
--
Div Yield TTM
--
P/B
0.55
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.16%
Amplitude
7.88%
Avg Price
2.500
Lot Size
1
Float Cap
12.75M
Bid/Ask %
0.00%
Historical High
184.000
Shs Float
5.12M
Volume Ratio
0.38
Historical Low
2.250
Dividend TTM
--
P/B
0.55
Dividend LFY
--
Turnover Ratio
0.16%
Amplitude
7.88%
Avg Price
2.500
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Anchiano Therapeutics Ltd. is a clinical-stage biopharmaceutical company, which engages in tin the discovery, development and commercialization of drugs for cancer-related diseases. Its products include two drugs for cancer BC-819 and BC-821. The company was founded by Avraham Hochberg in 2004 and is headquartered in Jerusalem, Israel.
CEO: Mr. Dale R. Pfost,PhD
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...